Stoxx Europe 50
|
5 538,01
|
10,99
|
0,20 %
|
Analysen zu Stoxx Europe 50-Werten
| 16.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 16.02.26 | Hermès Equal Weight | Barclays Capital | |
| 16.02.26 | AXA Buy | Deutsche Bank AG | |
| 16.02.26 | SAFRAN Buy | Deutsche Bank AG | |
| 16.02.26 | UniCredit Hold | Deutsche Bank AG | |
| 16.02.26 | AB InBev Hold | Deutsche Bank AG | |
| 16.02.26 | Siemens Energy Buy | Deutsche Bank AG | |
| 16.02.26 | Siemens Buy | UBS AG | |
| 16.02.26 | L'Oréal Buy | UBS AG | |
| 16.02.26 | L'Oréal Overweight | Barclays Capital | |
| 16.02.26 | Nestlé Equal Weight | Barclays Capital | |
| 16.02.26 | Airbus Outperform | Bernstein Research | |
| 16.02.26 | Hermès Outperform | Bernstein Research | |
| 16.02.26 | Siemens Energy Outperform | RBC Capital Markets | |
| 16.02.26 | AB InBev Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.02.26 | Iberdrola Neutral | JP Morgan Chase & Co. | |
| 16.02.26 | BNP Paribas Equal Weight | Barclays Capital | |
| 16.02.26 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 16.02.26 | SAFRAN Outperform | RBC Capital Markets | |
| 13.02.26 | UniCredit Buy | Goldman Sachs Group Inc. | |
| 13.02.26 | AB InBev Buy | Goldman Sachs Group Inc. | |
| 13.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 13.02.26 | Hermès Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.02.26 | RELX Outperform | Bernstein Research | |
| 13.02.26 | Siemens Energy Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.02.26 | AB InBev Outperform | Bernstein Research | |
| 13.02.26 | L'Oréal Neutral | JP Morgan Chase & Co. | |
| 13.02.26 | L'Oréal Market-Perform | Bernstein Research | |
| 13.02.26 | SAFRAN Outperform | Bernstein Research | |
| 13.02.26 | Siemens Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | UniCredit Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | Santander Buy | Goldman Sachs Group Inc. | |
| 13.02.26 | RELX Buy | UBS AG | |
| 13.02.26 | AB InBev Buy | UBS AG | |
| 13.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 13.02.26 | GSK Buy | Jefferies & Company Inc. | |
| 13.02.26 | SAFRAN Neutral | UBS AG | |
| 13.02.26 | L'Oréal Overweight | Barclays Capital | |
| 13.02.26 | L'Oréal Buy | UBS AG | |
| 13.02.26 | RELX Overweight | Barclays Capital |